Osteometabolic profile and bone mass in the transition phase: ethnic differences in Brazilians treated with somatropin during childhood

OBJECTIVE: The main growth hormone action is to promote linear growth increasing protein synthesis stimulation and osteoblastic activity. Peak bone mass extends from adolescence to 30 years of age. Several factors may influence this acquisition and prevent fracture risk in adulthood, such as genetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuba, Valesca M., Castro, Antonia B.S., Leone, Cláudio, Damiani, Durval
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031360/
https://www.ncbi.nlm.nih.gov/pubmed/36155741
http://dx.doi.org/10.1016/j.jped.2022.08.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031360/
https://www.ncbi.nlm.nih.gov/pubmed/36155741
http://dx.doi.org/10.1016/j.jped.2022.08.001

Ejemplares similares